Intraoperative radiation therapy (IORT) is a cutting-edge form of radiation therapy that is used during the surgical procedure to treat cancer. This type of radiation therapy is used to target a localized area of the body with high doses of radiation, allowing for more precise treatment of cancerous tissue. IORT is particularly useful for treating tumors that are in close proximity to vital organs and structures, as it eliminates the need for external radiation therapy, reducing the risk of damage to healthy tissue.
The global intraoperative radiation therapy market is expected to experience significant growth in the coming years due to the increasing prevalence of cancer and the growing demand for advanced treatments. Additionally, the growing awareness among patients and healthcare professionals about the potential benefits of IORT is expected to further drive the market growth. Furthermore, the increasing acceptance of IORT by healthcare providers and the introduction of technologically advanced equipment are some of the other factors that are anticipated to fuel the growth of the market.
According to the new market research report “Intraoperative Radiation Therapy Market by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application (Breast, Brain, Lung Cancer) – Global Forecasts to 2025″, published by MarketsandMarkets™, the Intraoperative radiation therapy products market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.
Request For Free Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083
Key Market Players
The key growth strategies adopted by the top players in the market are product launches and approvals, agreements, partnerships, mergers and acquisitions, and expansions. Prominent players in the intraoperative radiation therapy market include ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems Inc. (US), Xstrahl Medical (UK), DOSIsoft SA (France), Huiheng Medical (China), Sun Nuclear Corporation (US), and Theragenics Corporation (US).
ZEISS is among the pioneer companies that combined surgery with radiotherapy to develop and introduce intraoperative radiation therapy to the cancer treatment field. The flagship product of the company, INTRABEAM, is one of the most widely used IORT products across the globe. INTRABEAM is a revolutionary, intraoperative form of radiation therapy for early-stage breast cancers. It allows radiation treatment and breast-conserving surgery to be performed simultaneously.
The market is segmented on the basis of product, application, and geography. Based on product, the market is bifurcated into dedicated IORT systems and afterloaders. By application, the market is divided into breast cancer, gynecological cancer, and other cancers. Regionally, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083
This report has segmented the global Intraoperative radiation therapy market into following segments & sub-segments:
By Product & Service
- Applicators & Afterloaders
- Treatment Planning Systems
- Electron IORT
- Intraoperative Brachytherapy
- Breast Cancer
- Brain Tumor
- Gastrointestinal Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Endometrial & Cervical Cancer
- Lung Cancer
- Other Cancers (penile cancer and prostate cancer)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- Elekta AB launched Geneva, a universal gynecological applicator for brachytherapy.
- Varian acquired Cancer Treatment Services International (CTSI), a US-based oncology solutions division that provides cancer care professional services to healthcare providers worldwide. The acquisition expanded Varian’s access to technology-driven cancer care .
- Varian launched the Bravos afterloader system for high-dose-rate (HDR) brachytherapy treatments
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=245000083
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Address:630 Dundee Road Suite 430
State: IL 60062
Country: United States